News
Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...
Hosted on MSN17d
GSK buys US-based rare cancer treatment developer for up to £1bnaccording to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...
In its 2024 Global Cancer Statistics report, the American Cancer Society has brought attention ... plan that includes ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
The British biopharmaceutical company GlaxoSmithKline Plc (GSK) has entered into an agreement ... with offices in 150 countries. IDRx is an American biopharmaceutical company developing cancer ...
When back pain, exhaustion and respiratory infections hit, Allison Freedman blamed her busy life. At 42, the active mom of twins had just completed an M.B.A program and started a new job, after ...
GSK is funding ... for 2024 are American Heart Association, American Lung Association, American Pharmacists Association, Asthma and Allergy Foundation of America, Autism Society, Ever Thrive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results